These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 27793756)

  • 1. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
    Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
    Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
    Huang WT; Larsson M; Wang YJ; Chiou SH; Lin HY; Liu DM
    Mol Pharm; 2015 Apr; 12(4):1242-9. PubMed ID: 25760774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.
    Chen YY; Lin YJ; Huang WT; Hung CC; Lin HY; Tu YC; Liu DM; Lan SJ; Sheu MJ
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
    Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
    Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of quercetin and pH-responsive DEAE-chitosan carriers as drug delivery system for breast cancer treatment.
    de Oliveira Pedro R; Goycoolea FM; Pereira S; Schmitt CC; Neumann MG
    Int J Biol Macromol; 2018 Jan; 106():579-586. PubMed ID: 28807690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
    Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
    Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
    Motiei M; Kashanian S
    Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining cisplatin incorporation properties in thermosensitive injectable biodegradable hydrogel for sustained delivery and enhanced cytotoxicity.
    Abdel-Bar HM; Abdel-Reheem AY; Osman R; Awad GA; Mortada N
    Int J Pharm; 2014 Dec; 477(1-2):623-30. PubMed ID: 25445973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
    Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
    J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of rod-like chitosan-quinoline nanoparticles as pH-responsive nanocarriers for quercetin delivery.
    Rahimi S; Khoee S; Ghandi M
    Int J Biol Macromol; 2019 May; 128():279-289. PubMed ID: 30695722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
    Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
    Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
    Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
    Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin.
    Baghbani F; Chegeni M; Moztarzadeh F; Hadian-Ghazvini S; Raz M
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():186-193. PubMed ID: 28254284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
    Scarano W; de Souza P; Stenzel MH
    Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.
    Shali H; Shabani M; Pourgholi F; Hajivalili M; Aghebati-Maleki L; Jadidi-Niaragh F; Baradaran B; Movassaghpour Akbari AA; Younesi V; Yousefi M
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):293-302. PubMed ID: 28362176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells.
    Jiang J; Liu Y; Wu C; Qiu Y; Xu X; Lv H; Bai A; Liu X
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1304-1313. PubMed ID: 28402175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.